NRAS DNA G-quadruplex-targeting molecules for sequence-selective enzyme inhibition
Chemical Communications · 2024
DOI: 10.1039/d4cc03753g ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2024. Verfasst von Yoshiki Hashimoto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Frontiers of Innovative Research in Science and Technology, Konan University, 7-1-20 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan. Hauptthemen laut MEDLINE: G-Quadruplexes, Fluorescent Dyes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Hirao Taro Foundation of KONAN GAKUEN for Academic Research, Japan Society for the Promotion of Science, Asahi Glass Foundation.
Abstract (Originalsprache)
Sequence-selective G-quadruplex ligands are valuable for controlling gene expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Frontiers of Innovative Research in Science and Technology, Konan University, 7-1-20 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.
ORCID-Profile: Daisuke Miyoshi
Förderung
- Hirao Taro Foundation of KONAN GAKUEN for Academic Research
- Japan Society for the Promotion of Science
- Asahi Glass Foundation
- Japan Science and Technology Agency
Zitieren
APA
Hashimoto, Y., Kubo, H., Kawauchi, K., & Miyoshi, D. (2024). NRAS DNA G-quadruplex-targeting molecules for sequence-selective enzyme inhibition. Chemical Communications. https://doi.org/10.1039/d4cc03753g
Vancouver
Hashimoto Y, Kubo H, Kawauchi K, Miyoshi D. NRAS DNA G-quadruplex-targeting molecules for sequence-selective enzyme inhibition. Chemical Communications. 2024. doi:10.1039/d4cc03753g
BibTeX
@article{Hashimoto2024,
author = {Hashimoto, Yoshiki and Kubo, Hiroki and Kawauchi, Keiko and Miyoshi, Daisuke},
title = {NRAS DNA G-quadruplex-targeting molecules for sequence-selective enzyme inhibition},
journal = {Chemical Communications},
year = {2024},
doi = {10.1039/d4cc03753g}
}
EUVIMED